Methods of treating developmental disorders with gaboxadol

Abstract

Methods of treating developmental disorders such as Angelman syndrome, Fragile X syndrome, Fragile X-associated tremor/ataxia syndrome (FXTAS), Autistic Spectrum Disorder, Autism, Asperger's syndrome, pervasive developmental disorder, Childhood Disintegrative Disorder, Rett syndrome, Lanau-Kleffner Syndrome, Prader-Willi Syndrome, Tardive Dyskinesia, and/or Williams Syndrome with gaboxadol or a pharmaceutically acceptable salt thereof are provided. The methods provide therapeutic compositions that may be used to improve one or more symptoms of the developmental disorder.

What is claimed is: 
     
         1 . A method of treating Fragile X syndrome, said method comprising orally administering to a patient in need thereof a pharmaceutical composition comprising a compound according to formula I: 
       
         
           
           
               
               
           
         
         wherein about 1 mg to about 10 mg of the compound according to formula 1 is administered in a 24-hour period.